Utah · Medicare · DXA scans, who qualifies and what treatment costs
Does Medicare Cover Bone Density Scans in Utah? (2026)
Yes. Medicare Part B pays for a bone density scan, usually a DXA, once every 24 months if you have a qualifying reason, and you pay nothing when the provider accepts assignment. The catch is that it is not a routine screening for everyone: Medicare lists five conditions, and most men don't meet any of them. Below are the rules, what Utahns on Medicare actually use, what osteoporosis drugs cost under Part B and Part D, and how Utah's hip fracture numbers compare.
The bottom line
- A DXA bone density scan is $0 under Part B if you qualify. Medicare covers one every 24 months (at least 23 months after the month of your last one), or more often if medically necessary. In 2024 Medicare paid 100% of the approved amount on Utah DXA scans: $29.06 at an imaging center, or an $8.34 reading fee plus the hospital's facility fee in a hospital.
- You need one of five reasons. A woman your doctor finds estrogen-deficient and at risk; X-rays showing possible osteoporosis or a spine fracture; steroid use (about 5 mg of prednisone a day for more than 3 months); primary hyperparathyroidism; or monitoring an osteoporosis drug. There is no routine screening benefit for men.
- Utah uses the benefit at about the national rate. 17,060 Utahns on Original Medicare had a DXA scan in 2024, or 9.3% of people with Part B, against 9.7% nationally (0.96 times the national rate). Utah's rate rose each year from 2022 to 2024.
- Treatment is where the costs are. Generic alendronate pills (Part D) averaged about $8.32 per fill in Utah's 2024 claims. An office denosumab shot (Part B) had an approved amount of about $1,528 per dose, so your 20% is about $306 after the $283 deductible, twice a year.
- Hip fractures are the reason it matters. Utah hospitals billed Original Medicare for 1,148 hip and femur fracture surgery stays in 2024, about 51.8 per 10,000 people with Part A, close to the national 49.8. Each stay starts with the $1,736 Part A deductible in 2026.
Osteoporosis is a disease you usually can't feel until a bone breaks. A DXA (dual-energy X-ray absorptiometry) scan measures bone density at the hip and spine in a few minutes, with a low radiation dose, and reports a T-score. A T-score of −2.5 or lower is osteoporosis; between −1 and −2.5 is low bone mass, often called osteopenia. CDC's National Center for Health Statistics found osteoporosis in 17.7% of U.S. adults 65 and older in 2017–2018, and in 19.6% of women and 4.4% of men 50 and older. Another 43.1% of adults 50 and older had low bone mass. For a Utah retiree who hikes, skis, gardens or shovels snow, a scan is how you find out before a fall does it for you.
Who qualifies for a Medicare-covered bone density scan?
Medicare calls the benefit a “bone mass measurement.” Your doctor or another qualified practitioner must order it, and you must fit at least one category in the federal rule, 42 CFR 410.31. Medicare.gov repeats the same list.
| You qualify if… | What the rule says | Notes |
|---|---|---|
| You are an estrogen-deficient woman at risk | Your treating doctor determines you are estrogen-deficient and at clinical risk for osteoporosis, based on your medical history and other findings | This is the route most women past menopause use; the doctor's documentation matters |
| An X-ray shows a problem | Vertebral (spine) abnormalities on X-ray indicating osteoporosis, osteopenia or a vertebral fracture | Applies to men and women |
| You take steroids | Glucocorticoid therapy averaging 5.0 mg of prednisone a day or more for more than 3 months, now or planned | Applies to men and women; can justify testing more often than every 24 months |
| You have primary hyperparathyroidism | A diagnosis of primary hyperparathyroidism | Applies to men and women |
| You are on an osteoporosis drug | Monitoring the response to an FDA-approved osteoporosis drug therapy, using a central (hip and spine) DXA | Applies to men and women |
| How often | At least 23 months after the month of your last bone mass measurement; more often if medically necessary | Scan in March 2025 → eligible again from February 2027 |
| What you pay | $0 with a provider who accepts assignment; no deductible, no coinsurance | A scan outside these rules can be billed to you; ask for a written notice (ABN) first |
Sources: 42 CFR 410.31, Bone mass measurement: Conditions for coverage and frequency standards — ecfr.gov; Medicare.gov, Bone mass measurements — medicare.gov.
Medicare's rule is narrower than the medical guidance. The U.S. Preventive Services Task Force's January 2025 recommendation says to screen all women 65 and older, plus younger postmenopausal women at higher risk, and found the evidence insufficient to recommend for or against routine screening in men. Medicare doesn't name an age at all. A man with no X-ray finding, no steroid use and no hyperparathyroidism has no covered reason, even if his doctor thinks a scan is a good idea. In that case the office should give you an Advance Beneficiary Notice before the scan so you can decide whether to pay.
What does a bone density scan cost with Medicare in 2026?
Nothing, if you qualify and the provider accepts assignment. CMS's 2024 claims file confirms it: for Utah DXA scans the average amount Medicare paid equals the average amount it approved, in both imaging centers and hospitals. The same is true for the related codes below. The scan is not where Utah retirees spend money on bone health. Treatment is.
Source: CMS, Medicare Physician & Other Practitioners by Geography and Service, 2024, Utah office and facility rows for 77080 and J0897 — data.cms.gov; CMS Medicare Monthly Enrollment.
| Service (code) | Utahns, 2024 | 2024 Utah average Medicare-approved amount | Your share in 2026, Original Medicare |
|---|---|---|---|
| DXA scan of hip, pelvis and spine, imaging center (77080) | 6,865 | $29.06 | $0.00 if you qualify |
| DXA scan, hospital: radiologist's reading fee (77080) | 10,195 | $8.34 + the hospital's facility fee | $0.00 if you qualify |
| DXA with vertebral fracture assessment (77085) | 333 | $38.40 (office) | $0.00 if you qualify |
| Peripheral DXA of forearm, finger or heel (77081) | 413 | $25.29 (office) | $0.00 if you qualify |
| Follow-up office visit with your doctor (99213) | — | $81.26 | Deductible, then $16.25 |
| Zoledronic acid infusion, once a year, drug only (J3489, 5 mg) | 912 | $32.37 + the infusion fee | Deductible, then $6.47 + 20% of the infusion fee |
| Denosumab injection every 6 months, drug only (J0897, 60 mg) | 2,993 | $1,528.00 | Deductible, then about $305.60 per dose |
| Romosozumab monthly injection, drug only (J3111, 210 mg) | 195 | $2,244.56 per month | Deductible, then about $448.91 per month |
Averages across Utah Original Medicare claims in 2024; office rows for drugs. Per-dose amounts are the Utah per-milligram average times a standard dose. These are not price quotes. Code J0897 also covers the higher denosumab dose used for cancer that has spread to bone, so its count includes some non-osteoporosis patients. Medicare paid about 80% of the approved amount on Utah denosumab claims, consistent with 20% coinsurance. Some Part B drugs have lower coinsurance in a given quarter because of inflation rebates. Source: CMS, Medicare Physician & Other Practitioners by Geography and Service, 2024 — data.cms.gov.
How many Utahns on Medicare get a bone density scan?
CMS counts 17,060 Utah beneficiaries with a hip-and-spine DXA in 2024: 10,195 in hospital settings and 6,865 at imaging centers and offices. That is 9.3% of the 183,494 Utahns with Part B in Original Medicare, against 9.7% nationally. Because the benefit is every 24 months, the share of people tested over any two-year stretch is higher than a single year's figure. Utah's rate has risen each year since 2022, but the national rate has risen faster.
Share of people with Part B in Original Medicare who had a DXA scan (77080) billed in each year; Utah bars solid, U.S. bars lighter. Source: CMS, Medicare Physician & Other Practitioners by Geography and Service, 2022, 2023 and 2024; CMS, Medicare Monthly Enrollment.
These counts leave out the 55.0% of Utah's Medicare population, 270,074 of 491,386 people in July 2026, who are in Medicare Advantage plans, because the CMS file covers Original Medicare claims only. They also count everyone with Part B, men included, while the benefit mainly reaches women. So the rate should be read as a comparison with the nation, not as the share of eligible women who were screened.
Which osteoporosis drugs does Medicare cover, and under which part?
Where the drug is given decides which part of Medicare pays. That changes what you owe.
- Pills you take at home are Part D. Alendronate, ibandronate, risedronate and raloxifene are on most Part D formularies. Self-injected drugs such as teriparatide and abaloparatide are also Part D, often on a specialty tier with prior authorization. Since 2025, what you pay for covered Part D drugs counts toward the yearly out-of-pocket cap.
- Drugs a clinician gives you in the office are generally Part B. Denosumab shots every six months, a once-a-year zoledronic acid infusion, and monthly romosozumab injections show up in CMS's Part B claims file for Utah offices. You pay 20% after the deductible.
- A narrow home-health benefit. Medicare.gov says Part A and Part B cover osteoporosis injections given by a home health nurse to a woman who qualifies for Medicare home health care, has a fracture her provider certifies is related to postmenopausal osteoporosis, and can't inject herself, with no family member or caregiver able to. The nurse visit is $0; the drug is up to 20% after the Part B deductible.
| Drug (2024 Utah Part D claims) | Utah Part D enrollees using it | What the numbers show |
|---|---|---|
| Alendronate (generic pill) | 19,786 | 5.4% of Utah Part D enrollees vs. 4.4% nationally (1.23x); total drug cost about $8.32 per fill |
| Ibandronate (generic pill) | 1,651 | Monthly pill |
| Raloxifene (generic pill) | 1,114 | Daily pill, a different drug class |
| Prolia (denosumab) through Part D | 1,027 | About $1,730 total cost per fill; most Utah denosumab is billed to Part B instead (2,993 beneficiaries) |
| Teriparatide or abaloparatide (self-injected) | about 336 | Daily injections for high fracture risk; high-cost specialty drugs |
Total drug cost includes what the plan, the enrollee and others paid; it is not your copay. Teriparatide count adds brand and generic rows and may double-count people who switched. Source: CMS, Medicare Part D Prescribers by Geography and Drug, 2024 — data.cms.gov; Medicare.gov, Osteoporosis drugs — medicare.gov.
One Utah figure stands out. Utah Part D enrollees fill alendronate at 1.23 times the national rate, while Utah's DXA rate is a little below the nation's. Part of that is who is counted: the Part D figure includes people in Medicare Advantage drug plans, while the DXA figure covers Original Medicare only. If you are getting a drug plan for 2027, check that the osteoporosis drug you take is on the formulary and what tier it is on before December 7.
How common are hip fractures in Utah's Medicare population?
A hip fracture is the outcome bone density testing tries to prevent, and it is expensive. CMS's inpatient file counts 1,148 Original Medicare hospital stays in Utah in 2024 for hip and femur fracture surgery or for a hip replacement done because of a hip fracture. That is about 51.8 stays per 10,000 Utahns with Part A in Original Medicare, against 49.8 nationally (0.52% and 0.50%).
| Hospital stay (DRG) | Utah stays, 2024 | U.S. stays, 2024 | Utah average total payment |
|---|---|---|---|
| Hip and femur procedures (not joint replacement), with major complications (480) | 177 | 28,008 | $24,495 |
| Hip and femur procedures (not joint replacement), with complications (481) | 481 | 66,798 | $16,982 |
| Hip and femur procedures (not joint replacement), without complications (482) | 111 | 14,682 | $13,725 |
| Hip replacement for a hip fracture, with major complications (521) | 79 | 15,258 | $23,347 |
| Hip replacement for a hip fracture, without major complications (522) | 300 | 42,552 | $17,083 |
| Total | 1,148 | 167,298 | — |
DRGs 480–482 include femur fractures as well as hip fractures, and not every fracture is caused by osteoporosis. Elective hip replacements are excluded. Average total payment is the hospital payment from Medicare, the patient and other payers. Source: CMS, Medicare Inpatient Hospitals by Geography and Service, 2024 — data.cms.gov.
Under Original Medicare, that stay costs you the $1,736 Part A deductible in 2026, plus 20% of the surgeon's, anesthesiologist's and other doctors' bills under Part B. Rehab in a skilled nursing facility often follows. See our guides to falls and long-term care in Utah and the Medicare 100-day skilled nursing benefit.
How do Medicare Advantage and Medigap handle bone density and treatment?
Medicare Advantage plans must cover everything Original Medicare covers, so a qualifying DXA scan from an in-network provider is $0. Office-given drugs such as denosumab are usually covered under the plan's Part B drug benefit with coinsurance of up to 20%, often with prior authorization, and count toward the plan's yearly in-network out-of-pocket limit. Pills are on the plan's drug formulary. Check both during the Annual Enrollment Period.
With Original Medicare plus a Medigap policy, the scan is $0 and Medigap pays the Part B coinsurance on visits, infusions and shots. Plan G leaves you the $283 Part B deductible once a year. Plan N is similar, with copays of up to $20 for some office visits. Medigap doesn't cover Part D pills, so you'd add a stand-alone drug plan.
A St. George example: a scan, then two denosumab shots
Consider a 68-year-old retired teacher in St. George in Original Medicare without a Medigap policy. Her doctor documents that she is past menopause and at risk, because her mother broke a hip. Her DXA shows a spine T-score of −2.7, which is osteoporosis. She can't tolerate alendronate pills, so her doctor starts denosumab shots in the office every six months.
| Step | Medicare-approved amount (2024 Utah average) | Your share in 2026 |
|---|---|---|
| DXA bone density scan at an imaging center (77080) | $29.06 | $0.00 (covered bone mass measurement) |
| Follow-up office visit to review results (99213) | $81.26 | Deductible, then 20% |
| Denosumab 60 mg injection in the office, dose 1 (J0897) | $1,528.00 | Deductible, then 20% |
| Denosumab 60 mg injection in the office, dose 2, six months later (J0897) | $1,528.00 | Deductible, then 20% |
| Total for the year | $3,166.31 | $853.85 (the $283 deductible plus 20% of the rest) |
Illustrative only, using 2024 Utah averages; not a price quote. The drug amount excludes any separate injection administration fee. Source: CMS, Medicare Physician & Other Practitioners by Geography and Service, 2024.
With Plan G she would owe only the $283 deductible, assuming no other Part B bills that year had already met it. With a Medicare Advantage plan she would owe $0 for the scan and the plan's Part B drug coinsurance on the shots, after any prior authorization. Generic alendronate under Part D, if she could take it, would cost far less. That is a decision for her and her doctor, but the coverage choice decides who pays.
What should a Utah retiree do about bone density?
- Find out if you qualify. Women past menopause: ask your doctor whether your history puts you at risk and whether they'll order a DXA. Men: ask whether steroid use, a spine X-ray finding or a parathyroid problem applies.
- Check the date of your last scan. Medicare pays again once 23 months have passed since the month of your last one. Raise it at your yearly Wellness visit.
- Use a provider that accepts assignment (and is in network, if you have Medicare Advantage). That is what makes the scan $0.
- If the scan isn't covered, read the ABN. An Advance Beneficiary Notice tells you the office expects Medicare to deny it. You can decline or agree to pay.
- If you start treatment, check which part pays. Pills are Part D. Office shots and infusions are Part B at 20%, which Medigap pays and Medicare Advantage limits with its out-of-pocket cap.
- Before December 7, 2026, check your 2027 plan. Confirm your osteoporosis drug is on the formulary, its tier, and any prior authorization rules. Use Medicare's Plan Finder or call the Utah SHIP at (877) 424-4640.
- Reduce fall risk at home. Icy sidewalks in a Utah winter, stairs and loose rugs are common fall hazards; a fall is how most hip fractures happen.
We help Utah retirees understand what their Medicare coverage pays for, including how Medigap, Medicare Advantage and Part D each handle bone density scans, Part B drug coinsurance and prescriptions, and how it fits with retirement income planning. Plain English, no pressure. Education, not advice. We do not offer every plan available in your area.
Talk to a planner →Frequently asked questions
Does Medicare cover bone density scans?
Yes. Medicare Part B covers a bone mass measurement, usually a DXA scan, once every 24 months (more often if medically necessary) if you meet at least one condition: you are a woman your doctor determines is estrogen-deficient and at risk for osteoporosis; X-rays show possible osteoporosis, osteopenia or a vertebral fracture; you take prednisone or a similar steroid, or plan to start; you have primary hyperparathyroidism; or you are being monitored to see whether an osteoporosis drug is working. You pay nothing if the provider accepts assignment. CMS's 2024 claims file shows Medicare paid 100% of the approved amount on Utah DXA scans.
How often will Medicare pay for a bone density test?
Once every 24 months as a rule. The federal regulation (42 CFR 410.31) says at least 23 months must have passed since the month of your last bone density test, so a scan in March 2025 can be repeated from February 2027. Medicare can cover it more often when it is medically necessary, for example if you have been on long-term steroid therapy for more than three months, or if your first test was not a central DXA and you need a DXA baseline for future monitoring.
Does Medicare cover bone density tests for men?
Only when a man meets one of the medical conditions in the rule: X-rays showing possible osteoporosis, osteopenia or a vertebral fracture; steroid therapy averaging 5 mg of prednisone a day or more for more than three months (or planned); primary hyperparathyroidism; or monitoring of an FDA-approved osteoporosis drug. There is no routine screening benefit for men. The U.S. Preventive Services Task Force's January 2025 recommendation also found the evidence insufficient to recommend routine screening for men.
How much do osteoporosis drugs cost with Medicare in Utah?
It depends on the drug and the part of Medicare that covers it. Pills such as alendronate are covered by Part D; the average total drug cost was about $8.32 per prescription fill in Utah in 2024, and your copay depends on your plan. Drugs a clinician gives in the office, such as denosumab injections or zoledronic acid infusions, are generally billed to Part B: in Utah in 2024 a 60 mg denosumab dose had a Medicare-approved amount of about $1,528, so your 20% would be about $306 per dose after the $283 deductible. Medigap Plan G pays that 20%. Women who qualify for home health and have a postmenopausal osteoporosis fracture can get covered injections at home, with $0 for the nurse visit.
How common are hip fractures among Utah Medicare beneficiaries?
In 2024, Utah hospitals billed Original Medicare for 1,148 inpatient stays for hip and femur fracture surgery or a hip replacement after a hip fracture (DRGs 480-482 and 521-522), about 52 per 10,000 people with Part A in Original Medicare, close to the national rate of 50 per 10,000. Medicare's average total payment for the most common of these stays was about $16,982 in Utah. Under Original Medicare, you would pay the $1,736 Part A deductible for the stay in 2026, plus 20% of the surgeon's and other doctors' bills.
Sources
- Medicare.gov — Bone mass measurements (Part B; once every 24 months, or more often if medically necessary; five qualifying conditions; you pay nothing if the provider accepts assignment): medicare.gov — bone mass measurements
- Medicare.gov — Osteoporosis drugs (Part A and Part B cover certain injectable osteoporosis drugs and home health nurse visits for eligible women; $0 for the nurse visit): medicare.gov — osteoporosis drugs
- Electronic Code of Federal Regulations — 42 CFR 410.31, Bone mass measurement: Conditions for coverage and frequency standards (23-month rule; 5.0 mg prednisone for more than 3 months): ecfr.gov — 42 CFR 410.31
- U.S. Preventive Services Task Force — Osteoporosis to Prevent Fractures: Screening, final recommendation, January 14, 2025: uspreventiveservicestaskforce.org
- CDC, National Center for Health Statistics — Data Brief No. 405, Osteoporosis or Low Bone Mass in Older Adults: United States, 2017–2018 (osteoporosis 12.6% at 50+, 19.6% of women, 4.4% of men, 17.7% at 65+; low bone mass 43.1%): cdc.gov — NCHS Data Brief 405
- CMS — 2026 Medicare Parts A & B Premiums and Deductibles, November 14, 2025 (Part B premium $202.90; Part B deductible $283; Part A deductible $1,736): cms.gov — 2026 premiums and deductibles
- CMS — Medicare Physician & Other Practitioners — by Geography and Service, 2022–2024 (Utah and National rows for 77080, 77085, 77081, 77078, J0897, J3489, J3111 and 99213): data.cms.gov — Physician by Geography and Service
- CMS — Medicare Part D Prescribers — by Geography and Drug, 2024 (Utah and National rows for alendronate, ibandronate, raloxifene, Prolia, Forteo, teriparatide and Tymlos): data.cms.gov — Part D by Geography and Drug
- CMS — Medicare Inpatient Hospitals — by Geography and Service, 2024 (DRGs 480, 481, 482, 521 and 522, Utah and National): data.cms.gov — Inpatient by Geography and Service
- CMS — Medicare Monthly Enrollment (2024: Part B Original Medicare Utah 183,494, U.S. 27,982,142; Part A Original Medicare Utah 221,500, U.S. 33,605,216; Part D Utah 366,921, U.S. 54,375,198; July 2026 Utah 491,386 beneficiaries, 270,074 in Medicare Advantage): data.cms.gov — Medicare Monthly Enrollment
- Utah Insurance Department — Medicare consumer page (Utah SHIP (877) 424-4640): insurance.utah.gov
About this article. Written by the Utah Retirement Income Data Desk and reviewed by Brian Penner, Retirement income & long-term care planner. Educational only — not medical, financial, or legal advice, and not a recommendation of any specific plan, provider, facility, test, drug or treatment. Whether to have a bone density scan, and which treatment to use, is a decision for you and your doctor. Coverage rules are quoted from Medicare.gov, the Code of Federal Regulations and the U.S. Preventive Services Task Force as of November 5, 2026. The Utah and national beneficiary counts, shares and average amounts are our own tabulation of CMS public use files (Physician & Other Practitioners, Part D Prescribers, Inpatient Hospitals and Medicare Monthly Enrollment). Those files count Original Medicare claims only (Part D includes all drug plans), attribute claims to the provider's state, and are revised by CMS periodically. Osteoporosis prevalence figures are national survey estimates. Average Medicare-approved amounts are not price quotes, Medicare Advantage descriptions are general and vary by plan, and the example is illustrative. Confirm costs with your plan, your provider, or 1-800-MEDICARE before you act. Utah Retirement Income is a licensed independent insurance agency (NPN 16493717) and is not a government agency. We are not connected with or endorsed by Medicare, the Centers for Medicare & Medicaid Services, the CDC, the U.S. Preventive Services Task Force, the State of Utah or any government program. We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area; please contact Medicare.gov, 1-800-MEDICARE, or your State Health Insurance Assistance Program — in Utah, the Utah SHIP at (877) 424-4640 — to get information on all of your options. A $0-premium Medicare Advantage plan is not free; you still pay the Part B premium ($202.90 a month in 2026 for most people) and the plan's cost-sharing. If you call or text us, you consent to be contacted at the number you provide about your options; message and data rates may apply, and you can opt out at any time by replying STOP.